Travelers (TRV) PT Lowered to $214 at Morgan Stanley

Morgan Stanley analyst Bob Huang lowered the price target on Travelers (NYSE: TRV) to $214.00 (from $230.00) while maintaining a Equalweight rating.

The analyst comments "Elevated loss ratio in Business Insurance and elevated expenses in Bond & Specialty insurance drove the earnings miss. Slower than expected premium growth in BI also contributed to the earnings miss. Going forward, we would focus on pricing and reserving as the key drivers of growth."

You May Also Be Interested In

• Marvell (MRVL) PT Raised to $325 at Oppenheimer
• Marvell (MRVL) Stock: Risk/Reward Skewed to the Upside Near-Term Following Selloff, Says Analyst
• Elastic NV. (ESTC) PT Raised to $100 at DA Davidson, Neutral Rating Maintained